Personalised neoantigen‐based therapy in colorectal cancer

Colorectal cancer (CRC) has become one of the most common tumours with high morbidity, mortality and distinctive evolution mechanism. The neoantigens arising from the somatic mutations have become considerable treatment targets in the management of CRC. As cancer‐specific aberrant peptides, neoantig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ya‐Juan, Li, Xiong, Chen, Ting‐Ting, Wang, Jia‐Xiang, Zhou, Yi‐Xin, Mu, Xiao‐Li, Du, Yang, Wang, Jia‐Ling, Tang, Jie, Liu, Ji‐Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623652/
https://www.ncbi.nlm.nih.gov/pubmed/37921274
http://dx.doi.org/10.1002/ctm2.1461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623652/
https://www.ncbi.nlm.nih.gov/pubmed/37921274
http://dx.doi.org/10.1002/ctm2.1461

Ejemplares similares